Copertina

Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Iris K. Minichmayr, Mohamad Shebley, Piet H. van der Graaf, Karthik Venkatakrishnan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines
di: Karthik Venkatakrishnan, et al.
Pubblicazione: (2025)

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
di: Qi Liu, et al.
Pubblicazione: (2024)

Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype‐Guided Precision Medicine
di: Liang Zhao, et al.
Pubblicazione: (2024)

Progress in Clinical Pharmacology in China: An Ongoing Evolution
di: Liang Zhao, et al.
Pubblicazione: (2025)

History and Evolution of Innovations in Clinical Pharmacology
di: Lawrence J. Lesko, et al.
Pubblicazione: (2025)

Moving the Needle for Oncology Dose Optimization: A Call for Action
di: Karthik Venkatakrishnan, et al.
Pubblicazione: (2024)

Interchanging Biosimilars Using Proteomics
di: Piet H. van der Graaf, et al.
Pubblicazione: (2025)

Weaning off ThoroughQTStudies
di: Mai Mehanna, et al.
Pubblicazione: (2024)

Best Practices for Pharmacokinetic Studies of New Chemical Entities
di: Ya‐Feng Wen, et al.
Pubblicazione: (2024)

Reflections on Model‐Informed Drug Development
di: Lawrence J. Lesko, et al.
Pubblicazione: (2024)

Liberty on Odaiba, Against the Silhouette of Tokyo Bay: Inspirations for Moving Hypothesis‐Generating Research to Patient‐Centered Therapeutics
di: Karthik Venkatakrishnan
Pubblicazione: (2026)

Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
di: Chanchala Kaddi, et al.
Pubblicazione: (2024)

Seasons of Growth: Reflections on the CPT Editor‐in‐Training Program
di: Matthijs W. van Hoogdalem, et al.
Pubblicazione: (2025)

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
di: Georgi I. Kapitanov, et al.
Pubblicazione: (2025)

Model‐Informed Selection of the Recommended Phase 2 Dosage for Anti‐TIGIT Immunotherapy Leveraging co‐Expressed PD‐1 Inhibitor Target Engagement
di: Irina Kareva, et al.
Pubblicazione: (2025)

Integrated Population Pharmacokinetic, Pharmacodynamic, and Safety Analyses to Inform Dosage Selection in the Clinical Development of the ATR Inhibitor Tuvusertib
di: Jatinder Kaur Mukker, et al.
Pubblicazione: (2025)

The Potential of Disease Progression Modeling to Advance Clinical Development and Decision Making
di: Mary Summer Starling, et al.
Pubblicazione: (2024)

The Role for Clinical Translational Pharmacology in Advancing Pharmacoequity
di: Sonya Tang Girdwood, et al.
Pubblicazione: (2025)

Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
di: Jaehee Shim, et al.
Pubblicazione: (2026)

The Future of Clinical Translational Pharmacology
di: Matthew L. Rizk, et al.
Pubblicazione: (2026)

American Society for Clinical Pharmacology and Therapeutics
Pubblicazione: (2026)

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
di: Mariam A. Ahmed, et al.
Pubblicazione: (2024)

Optimizing Dosage in Pharmacotherapy—Missing the Forest for the Trees
di: Susan M. Abdel‐Rahman, et al.
Pubblicazione: (2024)

Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy
di: Emiel Leegwater, et al.
Pubblicazione: (2024)

Integrating Clinical Variability into PBPK Models for Virtual Bioequivalence of Single and Multiple Doses of Tofacitinib Modified‐Release Dosage Form
di: Vivek Purohit, et al.
Pubblicazione: (2024)

Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs
di: Atiqur Rahman, et al.
Pubblicazione: (2024)

Emergence of Small Nucleic Acids as Drugs in Precision Medicine
di: Xing Cheng, et al.
Pubblicazione: (2025)

Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell Therapies
di: Hardik Mody, et al.
Pubblicazione: (2024)

From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology
di: Karen Rowland Yeo, et al.
Pubblicazione: (2026)

Correction to “Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies”
Pubblicazione: (2025)

A Translational Model‐Based Meta‐Analysis to Predict Tremor Incidence Associated with Serotonin Reuptake Transporter Inhibition
di: Sheetal K. Panday, et al.
Pubblicazione: (2025)

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development
di: Robin DiFrancesco, et al.
Pubblicazione: (2026)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
di: Mohamed Elmeliegy, et al.
Pubblicazione: (2024)

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology
di: Aaron S. Devanathan, et al.
Pubblicazione: (2025)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins
di: Yow‐Ming C. Wang, et al.
Pubblicazione: (2024)

New Horizons for Clinical Pharmacology & Therapeutics : Global Outreach for Optimal Patient Outcomes
di: Karen Rowland Yeo
Pubblicazione: (2025)

Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
di: Wei Gao, et al.
Pubblicazione: (2025)

Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
di: Ting Wang, et al.
Pubblicazione: (2025)

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails
di: Niels A. D. Guchelaar, et al.
Pubblicazione: (2024)

Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
di: Prathap Nagaraja Shastri, et al.
Pubblicazione: (2024)